Literature DB >> 920577

Propranolol in mitral stenosis during sinus rhythm.

S G Meister, T R Engel, G S Feitosa, R H Helfant, W S Frankl.   

Abstract

Patients with early symptomatic mitral stenosis usually suffer from pulmonary congestion on the basis of left atrial and pulmonary venous hypertension. They are often in sinus rhythm, and cardiac output is usually well maintained. Symptoms occur most often when heart rate, cardiac output, or both are increased. In this study, intravenous propranolol administered to patients with pure mitral stenosis in sinus rhythm resulted in significant reductions in mitral diastolic gradient (-7.1 mm. Hg +/- 1.6 SED), mean pulmonary wedge pressure (--6.9 mm. Hg +/- 1.2) and mean pulmonary artery pressures (--9.0 mm. Hg +/- 1.2). This was due to simultaneous reduction of heart rate (--13.0 beats/minute +/- 2.6 and cardiac output (--0.5 L./minute +/- 0.2). A small associated reduction of left ventricular systolic pressure (--5.1 mm. Hg +/- 2.6) was not accompanied by adverse clinical effects. A potential role for propranolol in medical management of pure mitral stenosis in the presence of sinus rhythm is suggested.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 920577     DOI: 10.1016/s0002-8703(77)80207-x

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  2 in total

1.  Failure of propranolol to improve exercise tolerance in patients with mitral stenosis in sinus rhythm.

Authors:  M M Bassan; J Michaeli; O Shalev
Journal:  Br Heart J       Date:  1987-09

2.  A comparative study of ivabradine and atenolol in patients with moderate mitral stenosis in sinus rhythm.

Authors:  Gopalan Nair Rajesh; Kalathingathodika Sajeer; Chakanalil Govindan Sajeev; Cicy Bastian; Desabandhu Vinayakumar; Kader Muneer; Vellani Haridasan; Dolly Mathew; Biju George; Mangalath Narayanan Krishnan
Journal:  Indian Heart J       Date:  2016-01-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.